PBYI — Puma Biotechnology Share News
0.000.00%
Last trade - 00:00- $581.24m
- $487.34m
- $228.37m
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
Brief: Puma Biotechnology Says Jury Verdict Was Entered In Favor Of Wyeth, And Against Astrazeneca
Puma Biotechnology Inc reports results for the quarter ended in March - Earnings Summary
Brief: Puma Biotechnology Q1 Adjusted EPS USD -0.05
Puma Biotechnology Inc expected to post a loss of 22 cents a share - Earnings Preview
Brief: Puma Biotechnology Says Court Denied AstraZeneca's Motion For Invalidity
Puma Biotechnology Inc reports results for the quarter ended in December - Earnings Summary
Brief: Puma Biotechnology Q4 Adjusted EPS USD 0.31
Puma Biotechnology Inc expected to post earnings of 30 cents a share - Earnings Preview
Brief: Puma Biotechnology Announces Phase II Clinical Trial Design for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
Puma Biotechnology Inc reports results for the quarter ended in September - Earnings Summary
Brief: Puma Biotechnology Q3 Adjusted EPS USD 0.18
Puma Biotechnology Inc expected to post earnings of 8 cents a share - Earnings Preview
Brief: Puma Biotechnology Receives FDA Orphan Drug Designation For Alisertib For The Treatment Of Small Cell Lung Cancer
Puma Biotech rises on FDA's 'orphan drug' tag for lung cancer drug
Brief: Puma Biotechnology Announces FDA Clearance Of IND For Alisertib In Small Cell Lung Cancer
Puma Biotechnology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Puma Biotechnology Q2 adjusted EPS USD 0.1
Puma Biotechnology Inc expected to post earnings of 1 cent a share - Earnings Preview